Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Fantini

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Protocols|April 5, 2007
High resolution colonoscopy in live miceC Becker, M C Fantini, M F Neurath
Mucosal Immunology|December 17, 2008
IL-21 comes of age as a regulator of effector T cells in the gutM C Fantini, G Monteleone, T T MacDonald
Gut|September 16, 2005
Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitisM C Fantini, C Becker, I Tubbe, et al.
Gut|June 14, 2005
In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopyC Becker, M C Fantini, S Wirtz, et al.
Cell Cycle (Georgetown, Tex.)|January 19, 2005
IL-6 signaling promotes tumor growth in colorectal cancerC Becker, M C Fantini, S Wirtz, et al.
Biology of Reproduction|September 24, 1999
Spatiotemporal patterns of expression of neurotrophins and neurotrophin receptors in mice suggest functional roles in testicular and epididymal morphogenesisM A Russo, M L Giustizieri, A Favale, et al.
Gut|May 10, 2006
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21G Monteleone, R Caruso, D Fina, et al.
Oncogene|September 2, 2014
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growthV De Simone, E Franzè, G Ronchetti, et al.
Cell Death & Disease|February 22, 2014
A functional role for Smad7 in sustaining colon cancer cell growth and survivalC Stolfi, V De Simone, A Colantoni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 7, 2025
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC)D Noviello, W Fries, A Orlando, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Protocols|April 5, 2007
High resolution colonoscopy in live miceC Becker, M C Fantini, M F Neurath
Mucosal Immunology|December 17, 2008
IL-21 comes of age as a regulator of effector T cells in the gutM C Fantini, G Monteleone, T T MacDonald
Gut|September 16, 2005
Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitisM C Fantini, C Becker, I Tubbe, et al.
Gut|June 14, 2005
In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopyC Becker, M C Fantini, S Wirtz, et al.
Cell Cycle (Georgetown, Tex.)|January 19, 2005
IL-6 signaling promotes tumor growth in colorectal cancerC Becker, M C Fantini, S Wirtz, et al.
Biology of Reproduction|September 24, 1999
Spatiotemporal patterns of expression of neurotrophins and neurotrophin receptors in mice suggest functional roles in testicular and epididymal morphogenesisM A Russo, M L Giustizieri, A Favale, et al.
Gut|May 10, 2006
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21G Monteleone, R Caruso, D Fina, et al.
Oncogene|September 2, 2014
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growthV De Simone, E Franzè, G Ronchetti, et al.
Cell Death & Disease|February 22, 2014
A functional role for Smad7 in sustaining colon cancer cell growth and survivalC Stolfi, V De Simone, A Colantoni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 7, 2025
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC)D Noviello, W Fries, A Orlando, et al.
Pageof 1